Humacyte is launching a Phase III study of its lab-grown blood vessel Humacyl in 350 patients with end-stage renal disease who are on hemodialysis and don’t qualify for a standard surgical treatment, and Boston’s Brigham & Women’s Hospital plans to take part. Plans to move ahead to Phase III follow a promising Phase II clinical study […]
Regenerative Medicine
Ligand Pharmaceuticals pays $18m for CorMatrix assets
Ligand Pharmaceuticals (NSDQ:LGND) said this week that it’s getting into the medical device arena with the nearly $18 million acquisition of multiple tissue repair assets from CorMatrix. San Diego-based Ligand said it paid $17.5 million for synthetic royalties on existing extracellular matrix products, including the CanGaroo ECM envelope for implantable electronic devices, and the right […]
Gore touts 1st implant of Synecor in CQI trial
W.L. Gore & Associates said today its Synecor biomaterial designed for hernia repair was used in the 1st procedure of its clinical quality improvement project. The robotically assisted surgical procedure was performed at the Our Lady of the Lake hospital in Baton Rouge, La. by Dr. Karl LeBlanc, the Newark, Del.-based company said. “I think that […]
Amniox Medical touts reimbursement wins, extended cryo lifespan
Amniox Medical this month touted a reimbursement win from Palmetto Medicare as well as a 2-year cryopreserved lifespan for its Neox Cord 1k as it attempts to position itself as a market leader in wound care. The Atlanta, Ga.-based company said that Palmetto Medicare recently included Amniox’s Neox Cord 1k and Neox 100 would allografts […]
Invo Bioscience launches InvoCell in US
INVO Bioscience said today it launched its InvoCell intravaginal culture infertility treatment system in the U.S., starting in Texas through the Center for Assisted Reproduction. INVOcell is designed for incubating eggs and sperm during fertilization during early embryo development and operates within a woman’s body, unlike in vitro fertilization which takes place in a laboratory, the company […]
Bone Biologics closes $5.8m round
Regenerative orthobiologic company Bone Biologics said it recently closed a $5.75 million round joined by the Musculoskeletal Transplant Foundation, Orthofix (NSDQ:OFIX) and Hankey Capital to support development of its bone graft substitute. Boston-based Bone Biologics is developing Nell-1, a bone growth factor designed to be an alternative to other bone growth factors used in surgical procedures such […]
Patient enrolled in InVivo Therapeutics trial succumbs to injuries
InVivo Therapeutics (NSDQ:NVIV) said today that the 8th patient enrolled in a clinical trial of its spinal scaffold succumbed to his injuries nearly 5 days after a severe car accident. The death appears to be unrelated to InVivo’s bioresorbable neuro-spinal scaffold, which is designed to help heal traumatic spinal cord injuries. The patient was implanted April 12 with […]
Organogenesis skins up $30m for expansion
Organogenesis said yesterday that it raised $30 million from existing investors to back its expansion plans. Canton, Mass.-based Organogenesis makes a line of regenerative medicine products designed to heal wounds. The company said it plans to use the proceeds to expand its sales force and commercial operations and to widen the reach of its PuraPly collagen […]
CryoLife buys Genesee BioMed’s PhotoFix pericardium patch
CryoLife Inc. (NYSE:CRY) said today it exercised its right to acquire Genesee BioMedical’s PhotoFix bovine pericardium patch for $2.3 million in cash. Atlanta, Ga.-based Cryolife said it had the option to purchase the patches after acquiring the distribution rights and a purchase option for PhotoFix in August 2014. “PhotoFix is a highly differentiated product that complements […]
Sen. Franken pushes for review of Medtronic Infuse study
Senator Al Franken (D-Minn.) is pushing for more details on Medtronic‘s (NYSE:MDT) study of its Infuse Bone Graft, saying that the product may have “potentially skewed the risk profile” for patients and exposed “insufficient vigilance” by the FDA, according to the Minneapolis Star Tribune. The senator raised these concerns in a letter to both Medtronic […]
Predictive Technology Group closes Renovo buyout, names new prez
Salt Lake City, Utah-based Predictive Technology Group (OTCMKTS:PRED) said today it closed its buy of ReNovo Biotech and tapped former ReNovo Biotech CEO Eric Olson as the new prez of Predictive Biotech. Predictive Biotech said the acquisition will allow it access to ReNovo’s cellular, tissue, biomaterial and regenerative medicine products, as well as access to its […]